{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:08:13Z","timestamp":1769731693186,"version":"3.49.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,2,3]],"date-time":"2020-02-03T00:00:00Z","timestamp":1580688000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,2,3]],"date-time":"2020-02-03T00:00:00Z","timestamp":1580688000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>The \u2018My Experience of Taking Medicines\u2019 (MYMEDS) questionnaire is a self-reporting tool for identifying modifiable adherence barriers among individuals prescribed post-myocardial infarction (MI) secondary prevention medicines (SPM) in clinical practice. It was found to be a useful tool to support the conduction of patient-centred consultation in cardiology outpatient leading to improved outcomes including better adherence to SPM and patient satisfaction. This study describes the rationale and development of the MYMEDS tool, its performance and usefulness in identifying modifiable barriers to adherence in cardiology medical practice including user feedback of 204 consecutive post-MI patients who completed an evaluation based on MYMEDS.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>Modifiable non-adherence factors were initially identified based on literature review and stakeholder feedback. A draft MYMEDS questionnaire was piloted in 10 patients and adapted accordingly. The final version comprises six sections, covering current medicines, understanding and satisfaction with medicines, concerns about medicines, practical adherence barriers, fitting medicines into daily routine, and adherence to individual SPMs. The questionnaire was mailed to post-MI patients who then attended an outpatient medicines optimisation clinic.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Mean age was 70.5\u2009years and 67.6% were male. The tool was effective in revealing modifiable adherence barriers that could be addressed during the consultation. There were high rates of concern that SPMs could be harmful (33.2%) or overprescribed (43.2%), practical issues with swallowing medicines (8.2%), opening packaging (7.3%) or accessing repeat prescriptions (5.2%), forgetfulness (19.7%), and concerns about inconvenience (13.5%). Mean number of barriers per patient was 1.8\u2009\u00b1\u20091.5. The medications most commonly associated with non-adherence were statins (21.5%), angiotensin II receptor blockers (21.1%), and antiplatelet agents (18.5%). In total, 42.5% of patients acknowledged non-adherence behaviour. Patient feedback on MYMEDS was positive, with near-unanimous agreement that it was simple, clear and not too long, and that it enabled them to raise any concerns they had about their medicines. Patients reported that their individual medicines related needs were better addressed.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>MYMEDS is a practical tool that can successfully identify modifiable barriers to SPM adherence which can be addressed in a clinical setting. It can be easily rolled out in daily clinical practice to enable individualised person-centred medicines optimisation consultation.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12872-020-01362-y","type":"journal-article","created":{"date-parts":[[2020,2,3]],"date-time":"2020-02-03T19:04:57Z","timestamp":1580756697000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["The my experience of taking medicines (MYMEDS) questionnaire for assessing medicines adherence barriers in post-myocardial infarction patients: development and utility"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9707-234X","authenticated-orcid":false,"given":"Rani","family":"Khatib","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nasrin","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alistair S.","family":"Hall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,2,3]]},"reference":[{"key":"1362_CR1","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.amjmed.2011.12.013","volume":"125","author":"S Naderi","year":"2012","unstructured":"Naderi S, Bestwick J, Wald D. Adherence to drugs that prevent cardiovascular disease: meta-analysis on 376,162 patients. Am J Med. 2012;125:882\u20137.","journal-title":"Am J Med"},{"key":"1362_CR2","doi-asserted-by":"publisher","first-page":"2940","DOI":"10.1093\/eurheartj\/eht295","volume":"34","author":"R Chowdhury","year":"2013","unstructured":"Chowdhury R, Khan H, Heydon E, et al. Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences. Eur Heart J. 2013;34:2940\u20138.","journal-title":"Eur Heart J"},{"key":"1362_CR3","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ahj.2013.09.014","volume":"167","author":"NK Choudhry","year":"2014","unstructured":"Choudhry NK, Glynn RJ, Avorn J, et al. Untangling the relationship between medication adherence and post-myocardial infarction outcomes: medication adherence and clinical outcomes. Am Heart J. 2014;167:51\u20138.","journal-title":"Am Heart J"},{"key":"1362_CR4","series-title":"Report for the National Co-ordinating Centre for NHS Service Delivery and Organisation R & D (NCCSDO)","volume-title":"Concordance, adherence and compliance in medicine taking","author":"R Horne","year":"2005","unstructured":"Horne R, Weinman J, Barber N, et al. Concordance, adherence and compliance in medicine taking. Report for the National Co-ordinating Centre for NHS Service Delivery and Organisation R & D (NCCSDO). 2005. www.netscc.ac.uk\/hsdr\/files\/project\/SDO_FR_08-1412-076_V01.pdf. Accessed 22 July 2019."},{"key":"1362_CR5","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1097\/00005650-199808000-00004","volume":"36","author":"DL Roter","year":"1998","unstructured":"Roter DL, Hall JA, Merisca R, et al. Effectiveness of interventions to improve patient compliance: a meta-analysis. Med Care. 1998;36:1138\u201361.","journal-title":"Med Care"},{"key":"1362_CR6","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1097\/01.mlr.0000114908.90348.f9","volume":"42","author":"MR DiMatteo","year":"2004","unstructured":"DiMatteo MR. Variations in patients\u2019 adherence to medical recommendations: a quantitative review of 50 years of research. Med Care. 2004;42:200\u20139.","journal-title":"Med Care"},{"key":"1362_CR7","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/01.mlr.0000129496.05898.02","volume":"42","author":"MC Garber","year":"2004","unstructured":"Garber MC, Nau DP, Erickson SR, et al. The concordance of self-report with other measures of medication adherence: a summary of the literature. Med Care. 2004;42:649\u201352.","journal-title":"Med Care"},{"key":"1362_CR8","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/1477-7525-8-99","volume":"8","author":"L Shi","year":"2010","unstructured":"Shi L, Liu J, Fonseca V, et al. Correlation between adherence rates measured by MEMS and self-reported questionnaires: a meta-analysis. Health Qual Life Outcomes. 2010;8:99.","journal-title":"Health Qual Life Outcomes"},{"key":"1362_CR9","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1001\/archinte.167.16.1798","volume":"167","author":"AK Gehi","year":"2007","unstructured":"Gehi AK, Ali S, Na B, Whooley MA. Self-reported medication adherence and cardiovascular events in patients with stable coronary heart disease. Arch Intern Med. 2007;167:1798\u2013803.","journal-title":"Arch Intern Med"},{"key":"1362_CR10","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1111\/j.1751-7176.2008.07572.x","volume":"10","author":"DE Morisky","year":"2008","unstructured":"Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure for hypertension control. J Clin Hypertens. 2008;10:348\u201354.","journal-title":"J Clin Hypertens"},{"key":"1362_CR11","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1185\/03007990802619425","volume":"25","author":"CA McHorney","year":"2009","unstructured":"McHorney CA. The adherence estimator: a brief, proximal screener for patient propensity to adhere to prescription medications for chronic disease. Curr Med Res Opin. 2009;25:215\u201338.","journal-title":"Curr Med Res Opin"},{"key":"1362_CR12","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1080\/08870440290001502","volume":"17","author":"R Horne","year":"2002","unstructured":"Horne R, Weinman J. Self-regulation and self-management in asthma: exploring the role of illness perceptions and treatment beliefs in explaining non-adherence to preventer medication. Psychol Health. 2002;17:17\u201332.","journal-title":"Psychol Health"},{"key":"1362_CR13","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/S0022-3999(99)00057-4","volume":"47","author":"R Horne","year":"1999","unstructured":"Horne R, Weinman J. Patients\u2019 beliefs about prescribed medicines and their role in adherence to treatments in chronic physical illness. J Psychosom Res. 1999;47:555\u201367.","journal-title":"J Psychosom Res"},{"key":"1362_CR14","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/sj.jhh.1001721","volume":"18","author":"S Ross","year":"2004","unstructured":"Ross S, Walker A, MacLeod MJ. Patient compliance in hypertension: role of illness perceptions and treatment beliefs. J Hum Hypertens. 2004;18:607\u201313.","journal-title":"J Hum Hypertens"},{"key":"1362_CR15","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1345\/aph.1K497","volume":"42","author":"U Khanderia","year":"2008","unstructured":"Khanderia U, Townsend KA, Erickson SR, et al. Medication adherence following coronary artery bypass graft surgery: assessment of beliefs and attitudes. Ann Pharmacother. 2008;42:192\u20139.","journal-title":"Ann Pharmacother"},{"key":"1362_CR16","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0738-3991(98)00107-4","volume":"37","author":"BL Svarstad","year":"1999","unstructured":"Svarstad BL, Chewning BA, Sleath BL, Claesson C. The brief medication questionnaire: a tool for screening patient adherence and barriers to adherence. Patient Educ Couns. 1999;37:113\u201324.","journal-title":"Patient Educ Couns"},{"key":"1362_CR17","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1097\/MLR.0b013e318269e121","volume":"50","author":"CI Voils","year":"2012","unstructured":"Voils CI, Maciejewski ML, Hoyle RH, et al. Initial validation of a self-report measure of the extent of and reasons for medication nonadherence. Med Care. 2012;50:1013\u20139.","journal-title":"Med Care"},{"issue":"suppl","key":"1362_CR18","doi-asserted-by":"publisher","first-page":"e1460","DOI":"10.1016\/S0735-1097(12)61461-2","volume":"59","author":"R Khatib","year":"2012","unstructured":"Khatib R, Hall A. Adherence to secondary prevention medicines by coronary artery disease patients \u2013 exploring barriers to inform interventions. J Am Coll Cardiol. 2012;59(suppl):e1460.","journal-title":"J Am Coll Cardiol"},{"issue":"supp 1","key":"1362_CR19","doi-asserted-by":"publisher","first-page":"P2515","DOI":"10.1093\/eurheartj\/eht308.P2515","volume":"34","author":"R Khatib","year":"2013","unstructured":"Khatib R, Hall A, Silcock J, et al. Exploring beliefs about medicines among adherent and non-adherent patients with coronary artery disease to establish medicines partnership. Eur Heart J. 2013;34(supp 1):P2515.","journal-title":"Eur Heart J"},{"key":"1362_CR20","doi-asserted-by":"publisher","first-page":"e000997","DOI":"10.1136\/openhrt-2018-000997","volume":"6","author":"R Khatib","year":"2019","unstructured":"Khatib R, Marshall K, Silcock J, et al. Adherence to coronary artery disease secondary prevention medicines: exploring modifiable barriers. Open Heart. 2019;6:e000997.","journal-title":"Open Heart"},{"key":"1362_CR21","doi-asserted-by":"publisher","first-page":"e000921","DOI":"10.1136\/openhrt-2018-000921","volume":"5","author":"R Khatib","year":"2018","unstructured":"Khatib R, Laverty U, Mcgawley G, et al. Re-engineering the post-myocardial infarction medicines optimisation pathway: a retrospective analysis of a joint consultant pharmacist- and cardiologist-led clinic model. Open Heart. 2018;5:e000921.","journal-title":"Open Heart."},{"key":"1362_CR22","volume-title":"Medicines adherence: involving patients in decisions about prescribed medicines and supporting adherence. Clinical Guideline 76","author":"National Institute for Health and Care Excellence","year":"2009","unstructured":"National Institute for Health and Care Excellence. Medicines adherence: involving patients in decisions about prescribed medicines and supporting adherence. Clinical Guideline 76. 2009. www.nice.org.uk\/Guidance\/CG76. Accessed 22 July 2019."},{"key":"1362_CR23","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1331\/JAPhA.2011.09154","volume":"51","author":"SM Lavsa","year":"2011","unstructured":"Lavsa SM, Holzworth A, Ansani NT. Selection of a validated scale for measuring medication adherence. J Am Pharm Assoc. 2011;51:90\u20134.","journal-title":"J Am Pharm Assoc"},{"key":"1362_CR24","first-page":"111","volume-title":"A behavioural approach to pharmacy practice","author":"R Horne","year":"2001","unstructured":"Horne R. Non-adherence to medication: causes and implications for care. In: Gard P, editor. (ed) A behavioural approach to pharmacy practice. Oxford: Blackwell; 2001. p. 111\u201330."},{"key":"1362_CR25","doi-asserted-by":"publisher","first-page":"3267","DOI":"10.1093\/eurheartj\/ehu364","volume":"35","author":"K Kolandaivelu","year":"2014","unstructured":"Kolandaivelu K, Leiden BB, O'Gara PT, Bhatt DL. Non-adherence to cardiovascular medications. Eur Heart J. 2014;35:3267\u201376.","journal-title":"Eur Heart J"},{"issue":"Supp1","key":"1362_CR26","first-page":"S59","volume":"19","author":"R Khatib","year":"2012","unstructured":"Khatib R, Hall A, Silcock J, et al. Adherent and non-adherent coronary heart disease patients\u2019 perceptions about medicines and healthcare services. Eur J Cardiovasc Prev Rehabil. 2012;19(Supp1):S59.","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"1362_CR27","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1136\/ejhpharm-2018-001725","volume":"26","author":"NC Wilhelmsen","year":"2019","unstructured":"Wilhelmsen NC, Eriksson T. Medication adherence interventions and outcomes: an overview of systematic reviews. Eur J Hosp Pharm. 2019;26:187\u201392.","journal-title":"Eur J Hosp Pharm"},{"key":"1362_CR28","volume-title":"Medicines optimisation: the safe and effective use of medicines to enable the best possible outcomes. NG5","author":"National Institute for Health and Care Excellence","year":"2015","unstructured":"National Institute for Health and Care Excellence. Medicines optimisation: the safe and effective use of medicines to enable the best possible outcomes. NG5. 2015. www.nice.org.uk\/guidance\/ng5. Accessed 22 July 2019."},{"key":"1362_CR29","doi-asserted-by":"publisher","first-page":"304","DOI":"10.4065\/mcp.2010.0575","volume":"86","author":"MT Brown","year":"2011","unstructured":"Brown MT, Bussell JK. Medication adherence: WHO cares? Mayo Clin Proc. 2011;86:304\u201314.","journal-title":"Mayo Clin Proc"},{"key":"1362_CR30","doi-asserted-by":"publisher","first-page":"e84238","DOI":"10.1371\/journal.pone.0084238","volume":"9","author":"R Khatib","year":"2014","unstructured":"Khatib R, Schwalm JD, Yusuf S, et al. Patient and healthcare provider barriers to hypertension awareness, treatment and follow up: a systematic review and meta-analysis of qualitative and quantitative studies. PLoS One. 2014;9:e84238.","journal-title":"PLoS One"},{"issue":"1","key":"1362_CR31","doi-asserted-by":"publisher","first-page":"e84","DOI":"10.1093\/pubmed\/fdy088","volume":"41","author":"KH Leslie","year":"2018","unstructured":"Leslie KH, McCowan C, Pell JP. Adherence to cardiovascular medication: a review of systematic reviews. J Public Health (Oxf). 2018;41(1):e84\u201394.","journal-title":"J Public Health (Oxf)"},{"key":"1362_CR32","volume-title":"Adherence to secondary prevention medicines by coronary heart disease patients. PhD [thesis]","author":"R Khatib","year":"2012","unstructured":"Khatib R. Adherence to secondary prevention medicines by coronary heart disease patients. PhD [thesis]. Bradford: University of Bradford; 2012. Available from: http:\/\/hdl.handle.net\/10454\/5484"},{"key":"1362_CR33","first-page":"1948","volume-title":"Remington\u2019s the science and practice of pharmacy","author":"BL Svarstad","year":"2000","unstructured":"Svarstad BL, Bultman DC. The patient: behavioral determinants. In: Gennaro AE, editor. Remington\u2019s the science and practice of pharmacy. 20th ed ed. Baltimore: Lippincott Williams & Wilkins; 2000. p. 1948\u201356.","edition":"20"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-020-01362-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12872-020-01362-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-020-01362-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,2]],"date-time":"2021-02-02T01:21:03Z","timestamp":1612228863000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-020-01362-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,3]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1362"],"URL":"https:\/\/doi.org\/10.1186\/s12872-020-01362-y","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,3]]},"assertion":[{"value":"31 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This was part of a service development project in clinical practice. The initial part of the study involved comments and feedback from our <i>cardiology patient and public involvement group<\/i> at our cardiology research unit. No ethics approval was needed. The project was designed and conducted in our outpatient cardiology department to improve patient experience and clinical practice. The new service included the sending of the MYMEDS questionnaire as standard practice to all patients attending the cardiology medicines optimisation outpatient clinic alongside their usual clinic invitation letter. All healthcare professionals involved had direct care responsibility for the patients attending the clinic. All participants had the option to take part by voluntarily and anonymously completing the post clinic survey which evaluated all aspects of the new outpatient service. Therefore, based on advice from our R&I department and in line with Health Research Authority guidance and its decision tools the project did not need ethics approval.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"46"}}